Time intervals to care and health service use experiences of uninsured cancer patients treated under public financing in Mexico City
- PMID: 37086645
- DOI: 10.1016/j.canep.2023.102366
Time intervals to care and health service use experiences of uninsured cancer patients treated under public financing in Mexico City
Abstract
Background: The present study assesses the time intervals from symptom discovery to treatment start and describes the health service use experiences of uninsured patients with cancer of the breast, cervix uteri, testicle, and prostate before their arrival to the cancer hospital.
Methods: This cross-sectional study included 1468 patients who were diagnosed between June 2016 and May 2017 and received treatment for the selected cancers in two of the largest public cancer hospitals in Mexico City, financed through Seguro Popular. Data was collected through a survey administered via face-to-face interviews with patients and a review of their medical files.
Results: The median time between detection (symptom discovery or first abnormal screening test) and treatment start was 6.6 months. For all types of cancer, the longest interval was the diagnostic interval -between the first use of healthcare services and the confirmation of cancer. Less than 20% cancer patients were diagnosed in the earliest stages that are associated with the best chances of long-term survival. The participants described a high use of private services for their first consultation, the use of several different types of health services and multiple consultations before arrival to the cancer centers, and 35% perceived being misdiagnosed by the first doctor they consulted.
Conclusions: Most cancer patients treated in the two largest public institutions available for the uninsured faced long delays to get diagnosed and started treatment at advanced stages. Strengthening quality and access for effective early cancer diagnosis and treatment is key to improve patient outcomes in low and middle-income settings.
Keywords: Access barriers; Cancer pathways; Early diagnosis; Health services use; Time intervals.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Breast Cancer Diagnostic Delays Among Young Mexican Women Are Associated With a Lack of Suspicion by Health Care Providers at First Presentation.J Glob Oncol. 2019 Jul;5:1-12. doi: 10.1200/JGO.19.00093. J Glob Oncol. 2019. PMID: 31335236 Free PMC article.
-
Understanding breast cancer patient pathways and their impact on survival in Mexico.J Cancer Policy. 2024 Jun;40:100482. doi: 10.1016/j.jcpo.2024.100482. Epub 2024 Apr 23. J Cancer Policy. 2024. PMID: 38663531
-
Barriers and Explanatory Mechanisms of Delays in the Patient and Diagnosis Intervals of Care for Breast Cancer in Mexico.Oncologist. 2018 Apr;23(4):440-453. doi: 10.1634/theoncologist.2017-0431. Epub 2017 Dec 28. Oncologist. 2018. PMID: 29284758 Free PMC article.
-
Health issues among foreign born uninsured children visiting an inner city pediatric emergency department.J Immigr Minor Health. 2011 Jun;13(3):434-44. doi: 10.1007/s10903-010-9386-9. J Immigr Minor Health. 2011. PMID: 20809340
-
Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas-Mexico border.Perspect Public Health. 2019 Jul;139(4):199-205. doi: 10.1177/1757913918793443. Epub 2018 Aug 17. Perspect Public Health. 2019. PMID: 30117782
Cited by
-
The Cervical Cancer Treatment Gap in Mexico Under Seguro Popular, 2006-2016.Health Syst Reform. 2023 Dec 31;9(1):2272371. doi: 10.1080/23288604.2023.2272371. Epub 2023 Nov 9. Health Syst Reform. 2023. PMID: 37944505 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical